vs
Side-by-side financial comparison of FVCBankcorp, Inc. (FVCB) and Invivyd, Inc. (IVVD). Click either name above to swap in a different company.
Invivyd, Inc. is the larger business by last-quarter revenue ($17.2M vs $16.9M, roughly 1.0× FVCBankcorp, Inc.). On growth, FVCBankcorp, Inc. posted the faster year-over-year revenue change (4377.5% vs 24.5%).
FVCBankcorp, Inc. is a Virginia-based U.S. bank holding company operating FVCbank, a community-focused financial institution. It provides a full range of personal and commercial banking products including deposit accounts, business and personal loans, mortgage services, and wealth management solutions, serving SMEs, professionals and individual consumers across the Mid-Atlantic region.
Invivyd, Inc. is a clinical-stage biopharmaceutical company focused on developing broadly neutralizing antibody therapies to prevent and treat serious viral infectious diseases. Its core research and development pipeline targets high-burden respiratory pathogens including respiratory syncytial virus, catering to unmet medical needs of global patient groups.
FVCB vs IVVD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $16.9M | $17.2M |
| Net Profit | — | $-11.1M |
| Gross Margin | — | — |
| Operating Margin | 43.7% | -73.0% |
| Net Margin | — | -64.3% |
| Revenue YoY | 4377.5% | 24.5% |
| Net Profit YoY | — | 40.0% |
| EPS (diluted) | $0.31 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $16.9M | $17.2M | ||
| Q3 25 | $416.0K | $13.1M | ||
| Q2 25 | $15.8M | $11.8M | ||
| Q1 25 | $382.0K | $11.3M | ||
| Q4 24 | $378.0K | $13.8M | ||
| Q3 24 | $412.0K | $9.3M | ||
| Q2 24 | $415.0K | $2.3M | ||
| Q1 24 | $359.0K | $0 |
| Q4 25 | — | $-11.1M | ||
| Q3 25 | $5.6M | $-10.5M | ||
| Q2 25 | $5.7M | $-14.7M | ||
| Q1 25 | $5.2M | $-16.3M | ||
| Q4 24 | — | $-18.4M | ||
| Q3 24 | $4.7M | $-60.7M | ||
| Q2 24 | $4.2M | $-47.2M | ||
| Q1 24 | $1.3M | $-43.5M |
| Q4 25 | 43.7% | -73.0% | ||
| Q3 25 | — | -84.0% | ||
| Q2 25 | 45.9% | -127.8% | ||
| Q1 25 | — | -149.7% | ||
| Q4 24 | — | -139.1% | ||
| Q3 24 | — | -670.0% | ||
| Q2 24 | — | -2175.2% | ||
| Q1 24 | — | — |
| Q4 25 | — | -64.3% | ||
| Q3 25 | 1341.1% | -79.7% | ||
| Q2 25 | 36.0% | -124.4% | ||
| Q1 25 | 1352.1% | -144.1% | ||
| Q4 24 | — | -133.5% | ||
| Q3 24 | 1133.3% | -653.1% | ||
| Q2 24 | 1001.2% | -2086.9% | ||
| Q1 24 | 373.3% | — |
| Q4 25 | $0.31 | $0.02 | ||
| Q3 25 | $0.31 | $-0.06 | ||
| Q2 25 | $0.31 | $-0.12 | ||
| Q1 25 | $0.28 | $-0.14 | ||
| Q4 24 | $0.27 | $-0.14 | ||
| Q3 24 | $0.25 | $-0.51 | ||
| Q2 24 | $0.23 | $-0.40 | ||
| Q1 24 | $0.07 | $-0.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $226.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $253.6M | $241.5M |
| Total Assets | $2.3B | $276.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $226.7M | ||
| Q3 25 | — | $85.0M | ||
| Q2 25 | — | $34.9M | ||
| Q1 25 | — | $48.1M | ||
| Q4 24 | — | $69.3M | ||
| Q3 24 | — | $106.9M | ||
| Q2 24 | — | $147.9M | ||
| Q1 24 | — | $189.4M |
| Q4 25 | $253.6M | $241.5M | ||
| Q3 25 | $249.8M | $93.1M | ||
| Q2 25 | $243.2M | $42.8M | ||
| Q1 25 | $242.3M | $54.1M | ||
| Q4 24 | $235.4M | $67.5M | ||
| Q3 24 | $230.8M | $83.2M | ||
| Q2 24 | $226.5M | $140.6M | ||
| Q1 24 | $220.7M | $178.5M |
| Q4 25 | $2.3B | $276.9M | ||
| Q3 25 | $2.3B | $139.2M | ||
| Q2 25 | $2.2B | $89.1M | ||
| Q1 25 | $2.2B | $103.7M | ||
| Q4 24 | $2.2B | $129.5M | ||
| Q3 24 | $2.3B | $161.9M | ||
| Q2 24 | $2.3B | $177.3M | ||
| Q1 24 | $2.2B | $215.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $23.9M | $-15.5M |
| Free Cash FlowOCF − Capex | $23.8M | — |
| FCF MarginFCF / Revenue | 140.7% | — |
| Capex IntensityCapex / Revenue | 0.3% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.9M | $-15.5M | ||
| Q3 25 | $7.6M | $-8.3M | ||
| Q2 25 | $3.3M | $-13.3M | ||
| Q1 25 | $5.4M | $-21.1M | ||
| Q4 24 | $18.2M | $-37.6M | ||
| Q3 24 | $4.7M | $-41.1M | ||
| Q2 24 | $1.6M | $-41.6M | ||
| Q1 24 | $7.2M | $-50.2M |
| Q4 25 | $23.8M | — | ||
| Q3 25 | $7.6M | — | ||
| Q2 25 | $3.3M | $-13.3M | ||
| Q1 25 | $5.4M | $-21.3M | ||
| Q4 24 | $18.1M | $-37.6M | ||
| Q3 24 | $4.6M | $-41.1M | ||
| Q2 24 | $1.5M | — | ||
| Q1 24 | $7.1M | $-50.4M |
| Q4 25 | 140.7% | — | ||
| Q3 25 | 1818.0% | — | ||
| Q2 25 | 20.8% | -112.9% | ||
| Q1 25 | 1413.6% | -188.2% | ||
| Q4 24 | 4786.0% | -272.2% | ||
| Q3 24 | 1121.8% | -441.6% | ||
| Q2 24 | 361.2% | — | ||
| Q1 24 | 1988.3% | — |
| Q4 25 | 0.3% | 0.0% | ||
| Q3 25 | 0.2% | 0.0% | ||
| Q2 25 | 0.1% | 0.1% | ||
| Q1 25 | 4.2% | 1.3% | ||
| Q4 24 | 37.3% | 0.0% | ||
| Q3 24 | 14.1% | 0.1% | ||
| Q2 24 | 12.8% | 0.0% | ||
| Q1 24 | 3.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.36× | — | ||
| Q2 25 | 0.58× | — | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.37× | — | ||
| Q1 24 | 5.34× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
